CD274 and melanoma: Programmed cell death-1 (PD-1), programmed cell death-1 ligand (PD-L1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) therapies are effective in some patients with melanoma or non-small-cell lung cancer (4–6).